Colorectal Cancer, Pancreatic Adenocarcinoma
Conditions
Keywords
survival
Brief summary
Prognostic and predictive value of assessing the patients micrometastasis status in blood and bone marrow when diagnosed GI cancer. 2 different patient subgroups are currently studied, patients with cancer of the pancreas and patients with liver metastasis secondary to colorectal cancer. Our hypothesis is that patients with detective circulating tumor cells in the blood or disseminated tumour cells in their bone marrow at diagnosis have a more advanced disease than negative patients. This information may be of therapeutic interest.
Detailed description
Oncological and overall outcome of the included patients are consecutively registrated at the out-patient clinic. At end of follow-up these survival data are analysed according to the presence of tumor cells in blood and bone marrow, and the prognostic impact of their presence are assessed.
Interventions
None listed
Sponsors
Oslo University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
1. Histological proven adenocarcinoma of the pancreas 2. Histological/radiological verified colorectal liver metastases 3. Consent capable patient 4. Signed written, informed consent
Exclusion criteria
1\. Patient'history of other malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival | 5 year |
Countries
Norway
Contacts
Primary ContactGro Wiedswang, MD,PhD
Backup ContactEvi Faleide, MD,PhD
Outcome results
None listed